AMPERSAND

Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics; biological and chemical agents for scientific and research use, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics; pharmaceutical preparations and therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics; pharmaceutical preparations and therapeutics for treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders

Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services